AUB
CORT icon

Atlantic Union Bankshares’s Corcept Therapeutics CORT Stock Holding History

Atlantic Union Bankshares’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-116
Closed -$4.04K – 1771
2025
Q4 		$4.04K Hold
116
– – ﹤0.01% 1418
2025
Q3 		$9.64K Buy
+116
New +$8.39K ﹤0.01% 1282

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Atlantic Union Bankshares's CORT Position: Q1 2026 in Review

Atlantic Union Bankshares sold out of Corcept Therapeutics (CORT) in Q1 2026, closing a stake of 116 shares — an estimated $4.04K sold.

Atlantic Union Bankshares first reported a position in CORT in Q3 2025 and held it in 2 quarters. The position peaked at $9.64K in Q3 2025. 351 funds tracked by Wall St. Rank hold CORT as of Q1 2026.

  • Atlantic Union Bankshares reported no remaining Corcept Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Atlantic Union Bankshares sold 116 Corcept Therapeutics shares in Q1 2026, an estimated $4.04K.
  • Atlantic Union Bankshares first reported a position in Corcept Therapeutics in Q3 2025 and held it in 2 quarters.
  • Atlantic Union Bankshares's Corcept Therapeutics position peaked at $9.64K in Q3 2025.
  • 351 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.